Number needed to treat for pricing costly anticancer drugs: The example of regorafenib in metastatic colorectal cancer

F. Graziano, E. Rulli, E. Biagioli, V. Catalano

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbermdw024
Pages (from-to)747-748
Number of pages2
JournalAnnals of Oncology
Issue number4
Publication statusPublished - Apr 1 2016

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this